Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

BRCA1 deficiency and synthetic lethality in leukemias; not only gene mutation matters.

Piwocka K, Podszywałow-Bartnicka P, Skorski T.

Postepy Biochem. 2018 Oct 15;64(2):141-147. doi: 10.18388/pb.2018_124. Review.

2.

Characteristics of live parameters of the HS-5 human bone marrow stromal cell line cocultured with the leukemia cells in hypoxia, for the studies of leukemia-stroma cross-talk.

Podszywalow-Bartnicka P, Kominek A, Wolczyk M, Kolba MD, Swatler J, Piwocka K.

Cytometry A. 2018 Jul;93(9):929-940. doi: 10.1002/cyto.a.23580. Epub 2018 Sep 3.

3.

PARP1 inhibitor eliminated imatinib-refractory chronic myeloid leukemia cells in bone marrow microenvironment conditions.

Podszywalow-Bartnicka P, Maifrede S, Le BV, Nieborowska-Skorska M, Piwocka K, Skorski T.

Leuk Lymphoma. 2019 Jan;60(1):262-264. doi: 10.1080/10428194.2018.1471602. Epub 2018 Jun 22. No abstract available.

PMID:
29932782
4.

Tyrosine kinase inhibitor-induced defects in DNA repair sensitize FLT3(ITD)-positive leukemia cells to PARP1 inhibitors.

Maifrede S, Nieborowska-Skorska M, Sullivan-Reed K, Dasgupta Y, Podszywalow-Bartnicka P, Le BV, Solecka M, Lian Z, Belyaeva EA, Nersesyan A, Machnicki MM, Toma M, Chatain N, Rydzanicz M, Zhao H, Jelinek J, Piwocka K, Sliwinski T, Stoklosa T, Ploski R, Fischer T, Sykes SM, Koschmieder S, Bullinger L, Valent P, Wasik MA, Huang J, Skorski T.

Blood. 2018 Jul 5;132(1):67-77. doi: 10.1182/blood-2018-02-834895. Epub 2018 May 21.

5.

IGH/MYC Translocation Associates with BRCA2 Deficiency and Synthetic Lethality to PARP1 Inhibitors.

Maifrede S, Martin K, Podszywalow-Bartnicka P, Sullivan-Reed K, Langer SK, Nejati R, Dasgupta Y, Hulse M, Gritsyuk D, Nieborowska-Skorska M, Lupey-Green LN, Zhao H, Piwocka K, Wasik MA, Tempera I, Skorski T.

Mol Cancer Res. 2017 Aug;15(8):967-972. doi: 10.1158/1541-7786.MCR-16-0468. Epub 2017 Jun 20.

6.

Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cells.

Nieborowska-Skorska M, Sullivan K, Dasgupta Y, Podszywalow-Bartnicka P, Hoser G, Maifrede S, Martinez E, Di Marcantonio D, Bolton-Gillespie E, Cramer-Morales K, Lee J, Li M, Slupianek A, Gritsyuk D, Cerny-Reiterer S, Seferynska I, Stoklosa T, Bullinger L, Zhao H, Gorbunova V, Piwocka K, Valent P, Civin CI, Muschen M, Dick JE, Wang JC, Bhatia S, Bhatia R, Eppert K, Minden MD, Sykes SM, Skorski T.

J Clin Invest. 2017 Jun 1;127(6):2392-2406. doi: 10.1172/JCI90825. Epub 2017 May 8.

7.

Stress granules assembly affects detection of mRNA in living cells by the NanoFlares; an important aspect of the technology.

Wolczyk M, Podszywalow-Bartnicka P, Bugajski L, Piwocka K.

Biochim Biophys Acta Gen Subj. 2017 May;1861(5 Pt A):1024-1035. doi: 10.1016/j.bbagen.2017.02.010. Epub 2017 Feb 13.

PMID:
28196667
8.

Increased phosphorylation of eIF2α in chronic myeloid leukemia cells stimulates secretion of matrix modifying enzymes.

Podszywalow-Bartnicka P, Cmoch A, Wolczyk M, Bugajski L, Tkaczyk M, Dadlez M, Nieborowska-Skorska M, Koromilas AE, Skorski T, Piwocka K.

Oncotarget. 2016 Nov 29;7(48):79706-79721. doi: 10.18632/oncotarget.12941.

9.

Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies.

Winiarska M, Bojarczuk K, Pyrzynska B, Bil J, Siernicka M, Dwojak M, Bobrowicz M, Miazek N, Zapala P, Zagozdzon A, Krol M, Syta A, Podszywalow-Bartnicka P, Pilch Z, Dabrowska-Iwanicka A, Juszczynski P, Efremov DG, Slabicki M, Zenz T, Le Roy A, Olive D, Rygiel TP, Leusen JH, Golab J.

MAbs. 2014;6(5):1300-13. doi: 10.4161/mabs.32106. Epub 2014 Oct 30.

10.

Downregulation of BRCA1 protein in BCR-ABL1 leukemia cells depends on stress-triggered TIAR-mediated suppression of translation.

Podszywalow-Bartnicka P, Wolczyk M, Kusio-Kobialka M, Wolanin K, Skowronek K, Nieborowska-Skorska M, Dasgupta Y, Skorski T, Piwocka K.

Cell Cycle. 2014;13(23):3727-41. doi: 10.4161/15384101.2014.965013.

PMID:
25483082
11.

Stimulators of mineralization limit the invasive phenotype of human osteosarcoma cells by a mechanism involving impaired invadopodia formation.

Cmoch A, Podszywalow-Bartnicka P, Palczewska M, Piwocka K, Groves P, Pikula S.

PLoS One. 2014 Oct 14;9(10):e109938. doi: 10.1371/journal.pone.0109938. eCollection 2014.

12.

NFAT1 and NFAT3 cooperate with HDAC4 during regulation of alternative splicing of PMCA isoforms in PC12 cells.

Kosiorek M, Podszywalow-Bartnicka P, Zylinska L, Pikula S.

PLoS One. 2014 Jun 6;9(6):e99118. doi: 10.1371/journal.pone.0099118. eCollection 2014.

13.

Hyperglycaemia modifies energy metabolism and reactive oxygen species formation in endothelial cells in vitro.

Dymkowska D, Drabarek B, Podszywałow-Bartnicka P, Szczepanowska J, Zabłocki K.

Arch Biochem Biophys. 2014 Jan 15;542:7-13. doi: 10.1016/j.abb.2013.11.008. Epub 2013 Dec 1.

PMID:
24295959
14.

The PERK-eIF2α phosphorylation arm is a pro-survival pathway of BCR-ABL signaling and confers resistance to imatinib treatment in chronic myeloid leukemia cells.

Kusio-Kobialka M, Podszywalow-Bartnicka P, Peidis P, Glodkowska-Mrowka E, Wolanin K, Leszak G, Seferynska I, Stoklosa T, Koromilas AE, Piwocka K.

Cell Cycle. 2012 Nov 1;11(21):4069-78. doi: 10.4161/cc.22387. Epub 2012 Oct 24.

15.

Increased acetylation of lysine 317/320 of p53 caused by BCR-ABL protects from cytoplasmic translocation of p53 and mitochondria-dependent apoptosis in response to DNA damage.

Kusio-Kobialka M, Wolanin K, Podszywalow-Bartnicka P, Sikora E, Skowronek K, McKenna SL, Ghizzoni M, Dekker FJ, Piwocka K.

Apoptosis. 2012 Sep;17(9):950-63. doi: 10.1007/s10495-012-0739-9.

PMID:
22696202
16.

Interaction of plasma membrane Ca(2+)-ATPase isoform 4 with calcineurin A: implications for catecholamine secretion by PC12 cells.

Kosiorek M, Podszywalow-Bartnicka P, Zylinska L, Zablocki K, Pikula S.

Biochem Biophys Res Commun. 2011 Jul 29;411(2):235-40. doi: 10.1016/j.bbrc.2011.06.098. Epub 2011 Jun 26.

PMID:
21740891
17.

Role of annexin A6 isoforms in catecholamine secretion by PC12 cells: distinct influence on calcium response.

Podszywalow-Bartnicka P, Kosiorek M, Piwocka K, Sikora E, Zablocki K, Pikula S.

J Cell Biochem. 2010 Sep 1;111(1):168-78. doi: 10.1002/jcb.22685.

PMID:
20506562
18.

Expression of oncogenic kinase Bcr-Abl impairs mitotic checkpoint and promotes aberrant divisions and resistance to microtubule-targeting agents.

Wolanin K, Magalska A, Kusio-Kobialka M, Podszywalow-Bartnicka P, Vejda S, McKenna SL, Mosieniak G, Sikora E, Piwocka K.

Mol Cancer Ther. 2010 May;9(5):1328-38. doi: 10.1158/1535-7163.MCT-09-0936. Epub 2010 May 4.

19.

Calcium- and pH-dependent localization of annexin A6 isoforms in Balb/3T3 fibroblasts reflecting their potential participation in vesicular transport.

Strzelecka-Kiliszek A, Buszewska ME, Podszywalow-Bartnicka P, Pikula S, Otulak K, Buchet R, Bandorowicz-Pikula J.

J Cell Biochem. 2008 May 15;104(2):418-34.

PMID:
18044716
20.

[Participation of annexins in Ca2+-regulated secretion of catecholamines].

Podszywałow-Bartnicka P, Strzelecka-Kiliszek A, Zylińska L, Bandorowicz-Pikuła J.

Postepy Biochem. 2007;53(2):164-8. Review. Polish.

PMID:
17969877
21.

Calcium- and proton-dependent relocation of annexin A6 in Jurkat T cells stimulated for interleukin-2 secretion.

Podszywalow-Bartnicka P, Strzelecka-Kiliszek A, Bandorowicz-Pikula J, Pikula S.

Acta Biochim Pol. 2007;54(2):261-71. Epub 2007 Jun 4.

22.

The role of intracellular cAMP in renal gluconeogenesis in view of differential action of various cAMP analogues.

Jagielski AK, Podszywałow-Bartnicka P, Derlacz RA, Bryła J.

Arch Biochem Biophys. 2005 Feb 15;434(2):282-8.

PMID:
15639228

Supplemental Content

Loading ...
Support Center